(S)-methyl 2-((S)-2-((S)-2-((2R,3S)-3-((2S,4R,5R,6R)-4-((2S,4R,5S,6R)-4-((2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yloxy)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-7-((2S,4R,5R,6R)-4-((2S,4R,5S,6R)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5,10-dihydroxy-6-methyl-4-oxo-1,2,3,4-tetrahydroanthracen-2-yl)-2-methoxyacetamido)-3-phenylpropanamido)-3-phenylpropanoate

ID: ALA4162655

Chembl Id: CHEMBL4162655

PubChem CID: 145958722

Max Phase: Preclinical

Molecular Formula: C68H90N2O25

Molecular Weight: 1335.46

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](OC)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1

Standard InChI:  InChI=1S/C68H90N2O25/c1-30-44(91-49-26-45(57(74)32(3)87-49)92-48-25-43(71)56(73)31(2)86-48)24-39-22-38-23-40(63(84-8)66(81)69-41(20-36-16-12-10-13-17-36)65(80)70-42(67(82)85-9)21-37-18-14-11-15-19-37)62(61(78)54(38)60(77)53(39)55(30)72)95-51-28-46(58(75)34(5)89-51)93-50-27-47(59(76)33(4)88-50)94-52-29-68(7,83)64(79)35(6)90-52/h10-19,22,24,31-35,40-43,45-52,56-59,62-64,71-77,79,83H,20-21,23,25-29H2,1-9H3,(H,69,81)(H,70,80)/t31-,32-,33-,34-,35-,40-,41+,42+,43-,45-,46-,47-,48+,49+,50+,51+,52+,56-,57-,58-,59+,62+,63+,64-,68+/m1/s1

Standard InChI Key:  WZHHXTGZCAEXHC-XXVIWCEOSA-N

Alternative Forms

1. Parent:

   

   ALA4162655

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1335.46

Molecular Weight (Monoisotopic): 1334.5833

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Mitra P, Eckenrode JM, Mandal A, Jha AK, Salem SM, Leggas M, Rohr J..  (2018)  Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers.,  61  (17): [PMID:30114371] [10.1021/acs.jmedchem.8b01107]

Source

Source(1):

• Scientific Literature